Cited by 168Treatment of Major DepressionNeurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Effects of a Dopamine Agonist Piribedil in Depressed Patients: Relationship of Pretreatment Homovanillic Acid to Antidepressant Response

Post, Robert M.·1978·Archives of General Psychiatry

DOI 10.1001/archpsyc.1978.01770290091008

Open this paper in CoChat — free account

Abstract

Piribedil, a compound that stimulates dopamine receptors in a relatively specific fashion, was administered to 11 hospitalized depressed patients. The dopamine agonist significantly decreased rapid eye movement (REM) sleep and percent REM sleep and increased REM latency. Piribedil decreased the probenecid-induced accumulation of the dopamine metabolite homovanillic acid (HVA) in CSF. A range of mild to moderate antidepressant effects was noted; one patient worsened and one developed recurrent manic episodes. The degree of improvement in depression was negatively correlated with pretreatment values of HVA in CSF (r = -.66, P less than .05). These data suggest that the heterogeneity of clinical response may be related to biological differences in depressed patients and that those with low initial dopaminergic function respond best to increased dopamine receptor stimulation.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1978.01770290091008

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
A manual for standardized terminology, techniques and scoring system for sleep stages in human subjects
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 11,772
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,568
Norepinephrine in Depressive Reactions
Bunney, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,166
"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
Åsberg, M., Thorén, P., Traskman, L., Bertilsson, L., & Ringberger, V. (1976) · Science · doi:10.1126/science.1246632 · Cited by 682
Methods for Reliable Longitudinal Observation of Behavior
Bunney, W. E. (1963) · Archives of General Psychiatry · doi:10.1001/archpsyc.1963.01720150090010 · Cited by 480
REM latency: a psychobiologic marker for primary depressive disease.
Dj, K. (1976) · PubMed · Cited by 443
Clinical criteria for psychiatric diagnosis and DSM-III
Spitzer, R. L., Endicott, J., & Robins, E. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.11.1187 · Cited by 402

Show all 65 references

Sorted by citations

Items 101–168 of 168

Ventricular Size and CSF Transmitter Metabolite Concentrations in Severe Endogenous Depression
Standish‐Barry, H. M. A. S., Bouras, N., Hale, A. S., Bridges, P. K., & Bartlett, J. R. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.148.4.386 · Cited by 19
Mania‐induced remission of tardive dyskinesia in manic‐depressive illness
Weiner, W. J., & Werner, T. R. (1982) · Annals of Neurology · doi:10.1002/ana.410120241 · Cited by 19
Biochemical Effects of Antidepressant Treatment—Studies of Monoamine Metabolites in Cerebrospinal Fluid and Platelet [ 3 H]Imipramine Binding
Åsberg, M., & Wägner, A. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513361.ch5 · Cited by 18
Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients
Nordin, C. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06411.x · Cited by 15
Monoamine metablites as predictors of anttoepressant response: A critique
Kelwala, S., Jones, D. A., & Sitaram, N. (1983) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(83)90113-6 · Cited by 16
Effects of (-)eticlopride and 7-OH-DPAT on the tail-suspension test in mice
Ferrari, F., & Giuliani, D. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100409 · Cited by 16
Depression in Patients with Parkinson??s Disease
Zesiewicz, T., & Hauser, R. A. (2000) · CNS Drugs · doi:10.2165/00023210-200013040-00003 · Cited by 16
Altered pituitary hormone secretion in patients with pseudocyesis
Tulandi, T., McInnes, R. A., & Lal, S. (1983) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47423-6 · Cited by 16
Transmitter amines in depression
Curzon, G. (1982) · Psychological Medicine · doi:10.1017/s0033291700055562 · Cited by 16
Pharmacological evaluation of novel 1-[4-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea as potent anticonvulsant and antidepressant agent
Kumari, S., Mishra, C. B., & Tiwari, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.08.013 · Cited by 15
Dopamine uptake sites, labelled with [3H]GBR12935, in brain samples from depressed suicides and controls
Bowden, C., Cheetham, S. C., Lowther, S., Katona, C., Crompton, M. R., & Horton, R. W. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00423-9 · Cited by 12
Chapter 42 Prefrontal cortex stimulation as antidepressant treatment: mode of action and clinical effectiveness of rTMS
Padberg, F., Goldstein-Müller, B., Zwanzger, P., & Möller, H. (2003) · Supplements to Clinical neurophysiology · doi:10.1016/s1567-424x(09)70245-4 · Cited by 12
Use of the dopamine receptor agonist Mirapex in the treatment of Parkinson’s disease
Федорова, Н. В., & Chigir', I. P. (2007) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-007-0050-3 · Cited by 11
Monoaminergic‐based Pharmacotherapy for Depression
Papakostas, G. I., & D, M. F. M. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch6 · Cited by 11
The significance of biological factors in the diagnosis of depressions: II hormonal variables
van Praag, H. M. (1982) · Comprehensive Psychiatry · doi:10.1016/0010-440x(82)90069-4 · Cited by 11
The ‘cerebral diabetes’ paradigm for unipolar depression
Newman, J. C., & Holden, R. J. (1993) · Medical Hypotheses · doi:10.1016/0306-9877(93)90116-8 · Cited by 10
The Psychiatric Complications of Parkinson's Disease
Whitlock, F. A. (1986) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048678609161325 · Cited by 10
Noradrenergic Function in Affective Illness
Goodwin, F. K., & Potter, W. Z. (1979) · Elsevier eBooks · doi:10.1016/b978-0-08-023089-4.50020-x · Cited by 10
Cerebrospinal Fluid Amine Metabolite Studies in Depression: Research Update
Jimerson, D. C., & Berrettini, W. H. (1985) · Springer eBooks · doi:10.1007/978-3-642-69743-2_13 · Cited by 10
Dopamine and mental illness: And what about the mesocortical dopamine system?
Tassin, J. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0004766x · Cited by 9
The significance of biological factors in the diagnosis of depressions: I biochemical variables
van Praag, H. M. (1982) · Comprehensive Psychiatry · doi:10.1016/0010-440x(82)90057-8 · Cited by 9
MONOAMINES AND DEPRESSION: THE PRESENT STATE OF THE ART
van Praag, H. M. (1986) · Elsevier eBooks · doi:10.1016/b978-0-12-558703-7.50020-6 · Cited by 9
Add-on pramipexole for anhedonic depression: study protocol for a randomised controlled trial and open-label follow-up in Lund, Sweden
Lindahl, J., Asp, M., Ståhl, D., Tjernberg, J., Eklund, M., Björkstrand, J., van Westen, D., Jensen, J., Månsson, K. N. T., Tornberg, Å. B., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-076900 · Cited by 8
The prefrontal cortex — accumbens circuit: Who's in charge?
Jaskiw, G. E., & Weinberger, D. R. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047580 · Cited by 8
The effect of amitriptyline treatment on the growth hormone response to apomorphine
Cowen, P. J., Braddock, L., & Gosden, B. (1984) · Psychopharmacology · doi:10.1007/bf00428550 · Cited by 8
Clinical and Biological Correlates of Sleep Deprivation in Depression *
Joffe, R. T., & Brown, P. J. (1984) · The Canadian Journal of Psychiatry · doi:10.1177/070674378402900615 · Cited by 8
An Overview of Investigational Antidepressants
Berwish, N. J., & Amsterdam, J. D. (1989) · Psychosomatics · doi:10.1016/s0033-3182(89)72312-4 · Cited by 7
Apomorphine induced alteration in corneofundal potentials in depression
DeMet, E. M., Albers, L. J., Sokolski, K. N., Chicz-DeMet, A., Chen, C., & Reist, C. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00078-x · Cited by 6
Amineptine in the management of the depressive syndroms
Scarzella, L., Scarzella, R., Mailland, F., & Bergamasco, B. (1985) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(85)90197-6 · Cited by 6
Abnormalities in Catecholamines and the Pathophysiology of Bipolar Disorder
Garakani, A., Charney, D. S., & Anand, A. (2007) · CRC Press eBooks · doi:10.3109/9781420021158-6 · Cited by 6
DOPAMINERGIC MECHANISMS IN AFFECTIVE ILLNESS
Post, R. M., Cutler, N. R., Bunney, W. E., & Jimerson, D. C. (1981) · Elsevier eBooks · doi:10.1016/b978-0-08-026382-3.50011-6 · Cited by 5
Self-citation
Stoffwechselpathologie der Zyklothymie und Schizophrenie
Matussek, N. (1980) · Springer eBooks · doi:10.1007/978-3-642-67416-7_2 · Cited by 5
C n and C n‐1 B Fullerenes as Potential Nanovehicles for Piribedil Neuroprotective Drug (n=20, 36 and 60)
Reina, M., Celaya, C. A., & Muñiz, J. (2019) · ChemistrySelect · doi:10.1002/slct.201904211 · Cited by 4
An Open Field Study of Antidepressant Drugs
Dahl, C. B., & Götestam, K. G. (1989) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1989.tb00652.x · Cited by 4
Activit� et acceptabilit� du pirib�dil dans la maladie de Parkinson: �tude multicentrique
Rondot, P., & Ziegler, M. (1993) · Journal of Neurology · doi:10.1007/bf00879104 · Cited by 3
Mood disorders
Quiroz, J. A., Chen, G., Drevets, W. C., Henter, I. D., & Manji, H. K. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.004 · Cited by 3
Chapter 1 Antidepressants
Pinder, R. M. (1979) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61346-9 · Cited by 3
An electrophysiologist's eye view of the basal ganglia
Grace, A. A. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047567 · Cited by 3
The ghost in the machine: What if the midbrain output is excitatory?
Fallon, J. H. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047531 · Cited by 3
Dopamine and mental illness: Phenomenological and anatomical considerations
Kelley, A. E. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047609 · Cited by 3
Parkinsonism and Depression: Dopaminergic Mediation of Neuropathologic Processes in Human Beings
Holcomb, H. H. (1985) · Elsevier eBooks · doi:10.1016/b978-0-409-95184-4.50018-7 · Cited by 3
Catecholamine Metabolism in Hyperactive Children
Brown, G. L., & Ebert, M. H. (1985) · Elsevier eBooks · doi:10.1016/b978-0-409-95184-4.50015-1 · Cited by 3
10.5 The Role of Dopamine in the Pathophysiology and Treatment of Major Depressive Disorder
Dunlop, B. W., & Nemeroff, C. B. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0040 · Cited by 2
Dopamine in REM Sleep Regulation
Khanday, M. A., Yadav, R. K., & Mallick, B. N. (2016) · Springer eBooks · doi:10.1007/978-3-319-46437-4_1 · Cited by 2
ПИРИБЕДИЛ: ПОКАЗАНИЯ ДЛЯ НАЗНАЧЕНИЯ В ПСИХИАТРИИ И НАРКОЛОГИИ
Bykov, Y. V., & Bekker, R. A. (2020) · Siberian Journal of Life Sciences and Agriculture · doi:10.12731/2658-6649-2020-12-4-38-83 · Cited by 2
Abnormalities in Catecholamines and the Pathophysiology of Bipolar Disorder
Garakani, A., Charney, D. S., & Anand, A. (2007) · Medical psychiatry · doi:10.3109/9781420021158.003 · Cited by 2
Perspectives in the treatment of the psychoneurological disorders: Affective disorders
Post, R. M., Jimerson, D. C., & Bunney, W. E. (1979) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(79)90071-7 · Cited by 2
Self-citation
The neuropathology of schizophrenia, mania, and depression: Diseases of cognitive initiation and switching?
Gardner, E. L. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047555 · Cited by 2
Intracellular considerations in models of psychopathology
Chute, D. L. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047518 · Cited by 2
Neural circuit models of psychopathology: Dancing on the precipice of neuromythology?
Fibiger, H. C. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047543 · Cited by 2
Biochemical and physiological mechanisms of action of carbamazepine in affective illness
Post, R. M., & Uhde, T. W. (1983) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-06689-6_13 · Cited by 2
Self-citation
Toward a unified neuropsychiatric hypothesis
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047683 · Cited by 1
Where have all the peptides gone?
Kalivas, P. W. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047592 · Cited by 1
The “extended amygdala” as a receptor area for psychotherapeutic drugs
Alheid, G. F., & Heimer, L. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0004749x · Cited by 1
Unified theories of psychoses and affective disorders: Are they feasible without accurate neural models of cognition and emotion?
Phillips, A. G. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047634 · Cited by 1
Psychopharmacology of psychosis: Still looking for missing links
Stevens, J. R. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047658 · Cited by 1
Neuropsychiatry: Pitfalls of inferring functional mechanisms from observed drug effects
Soubrié, P., & Carnoy, P. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047646 · Cited by 1
Madness and clarity
Wolkin, A., & Cancro, R. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047671
Toward a neurological psychiatry
Moal, M. L. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047622
Roles for glutamate and norepinephrine in Iimbic circuitry and psychopathology
Beart, P. M. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047506
Neurochemical effects of et 495 : Mechanism of action
Hiremagalur, Keshavan, J. H., Gurbani, N. K., & Dandiya, P. C. (1981) · Pharmacological Research Communications · doi:10.1016/s0031-6989(81)80029-x
The Pharmacological Basis for Parkinson's Disease Treatment
(2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.001
Oral dopamine agonists in the management of Parkinson's disease
Pagonabarraga, J., Marín‐Lahoz, J., & Kulisevsky, J. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.005
Drugs that affect autonomic functions or the extrapyramidal system
Nakaki, T. (2014) · Side effects of drugs annual · doi:10.1016/b978-0-444-62635-6.00013-9
Piribedil
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01294-4
Simple and rapid LC-MS/MS method for determination of Piribedil in human plasma
Alshishani, A., Hasan, I., Ghanayem, F., Al-khasawneh, S., & Dayah, A. A. (2022) · Pharmacia · doi:10.3897/pharmacia.63.e86447
Antidepressiva mit neuartigen Wirkmechanismen
Wachtel, H., Vry, J. D., Gläser, T., & Möller, H. (1993) · Springer eBooks · doi:10.1007/978-3-7091-3317-0_6
Mise en évidence du potentiel thérapeutique de l’adiponectine et de son rôle dans les effets antidépresseurs de l’environnement enrichi
Nicolas, S. (2018) · theses.fr (ABES) · doi:10.70675/95c9bfb5zd68ez43b8zbbf8z73847b3cd3db

Authors: Post, R. M.
Corresponding author: Post, Robert M.
ORCID: Post, Robert M.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 1978-05-01
Volume: 35
Issue: 5
Pages: 609
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.1978.01770290091008
OpenAlex: W1981234468
Cited by: 168
References: 65
Citations by year: 2023: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 4
FWCI: 7.95
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords: piribedil, dopamine agonists, depression, REM sleep, REM latency, homovanillic acid, cerebrospinal fluid, probenecid, antidepressant response, manic episodes, dopaminergic activity, individual differences in treatment response
MeSH terms: Adult, Bipolar Disorder, Clinical Trials as Topic, Depression, Double-Blind Method, Female, Homovanillic Acid, Humans, Male, Middle Aged, Phenylacetates, Piperazines, Piribedil, Psychiatric Status Rating Scales, Receptors, Dopamine, Sleep, REM

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effects of a Dopamine Agonist Piribedil in Depressed Patients: Relationship of Pretreatment Homovanillic Acid to Antidepressant Response

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks